genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2023

Cytotoxicity

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform
Bioprocessing

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform

John Sterling -
November 14, 2023
0
Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets
Drug Discovery

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets

Jonathan D Grinstein, PhD -
August 4, 2023
0
New Potential Parkinson’s Disease Target Identified
News

New Potential Parkinson’s Disease Target Identified

John Sterling -
April 21, 2023
0
Evaluating CAR T Cells: In Vitro Potency Assays for Production, Quality Control, Efficacy, and Safety
Sponsored

Evaluating CAR T Cells: In Vitro Potency Assays for Production, Quality Control, Efficacy, and Safety

Kathy Vuksanaj -
December 7, 2022
0
HIV’s Vpu Protein Makes It Harder for Antibodies to Recognize Infected Cells
News

HIV’s Vpu Protein Makes It Harder for Antibodies to Recognize Infected Cells

Julianna LeMieux, PhD -
November 9, 2022
0
Combating Solid Tumors with Adoptive T-Cell Therapy
Drug Discovery

Combating Solid Tumors with Adoptive T-Cell Therapy

Kathy Vuksanaj -
July 7, 2022
0
Culprit Behind Immunotherapy Resistance in Some Lymphomas Revealed
Cancer

Culprit Behind Immunotherapy Resistance in Some Lymphomas Revealed

Christina Jackson -
September 17, 2020
0
Vectors and Their Successful Husbandry
Bioprocessing

Vectors and Their Successful Husbandry

K. John Morrow Jr., PhD -
June 9, 2020
0
What 3D Imaging Means for Cancer Drug Discovery
Cancer

What 3D Imaging Means for Cancer Drug Discovery

Christina Jackson -
May 4, 2020
0
Five Prime Eliminates 70 Jobs in Restructuring
Cancer

Five Prime Eliminates 70 Jobs in Restructuring

Alex Philippidis -
October 11, 2019
0
123...11Page 1 of 11

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up